Highly Efficient Ultrasound-Driven Ti 3+ -Doped TiO 2 with Oxygen Vacancies: A Promising Visible-Light Catalyst for Complete Sonophotocatalytic Degradation of Tetracycline
Industrial & Engineering Chemistry Research · 27.03.2024 · 63 (12) · 5135-5147
DOI: 10.1021/acs.iecr.3c04429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Industrial & Engineering Chemistry Research, online erschienen am 13.03.2024. Verfasst von Jenson Samraj Jeyaprakash und 5 weiteren Autor:innen. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Jeyaprakash, J. S., Rajamani, M., Mani, P., Yazhini, C., Sonawane, S. H., & Neppolian, B. (2024). Highly Efficient Ultrasound-Driven Ti 3+ -Doped TiO 2 with Oxygen Vacancies: A Promising Visible-Light Catalyst for Complete Sonophotocatalytic Degradation of Tetracycline. Industrial & Engineering Chemistry Research, 63(12), 5135-5147. https://doi.org/10.1021/acs.iecr.3c04429
Vancouver
Jeyaprakash JS, Rajamani M, Mani P, Yazhini C, Sonawane SH, Neppolian B. Highly Efficient Ultrasound-Driven Ti 3+ -Doped TiO 2 with Oxygen Vacancies: A Promising Visible-Light Catalyst for Complete Sonophotocatalytic Degradation of Tetracycline. Industrial & Engineering Chemistry Research. 2024;63(12):5135-5147. doi:10.1021/acs.iecr.3c04429
BibTeX
@article{Jeyaprakash2024,
author = {Jeyaprakash, Jenson Samraj and Rajamani, Manju and Mani, Preeyanghaa and Yazhini, Crescentia and Sonawane, Shirish H. and Neppolian, Bernaurdshaw},
title = {Highly Efficient Ultrasound-Driven Ti 3+ -Doped TiO 2 with Oxygen Vacancies: A Promising Visible-Light Catalyst for Complete Sonophotocatalytic Degradation of Tetracycline},
journal = {Industrial & Engineering Chemistry Research},
year = {2024},
volume = {63},
number = {12},
pages = {5135--5147},
doi = {10.1021/acs.iecr.3c04429}
}
EUVIMED